Production and oestrogen regulation of FGF1 in normal and cancer breast cells

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1403, Issue 2, 1998, Pages 127-140

  El Yazidi, Ikram ^a   Renaud, Flore ^b   Laurent, Maryvonne ^b   Courtois, Yves ^b   Boilly Marer, Yolande ^a  

^a UNIV LILLE   (France)

^b AP HP   (France)

Author keywords

Breast; Cancer; Estrogen regulation; FGF1

Indexed keywords

ESTROGEN; TAMOXIFEN;

ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CANCER CELL; CELL PROLIFERATION; CELL SPECIFICITY; CELL TRANSFORMATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; GENETIC REGULATION; HORMONAL REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RECEPTOR UPREGULATION; TRANSCRIPTION REGULATION;

ALTERNATIVE SPLICING; AUTOCRINE COMMUNICATION; BREAST; BREAST NEOPLASMS; ESTRADIOL; FEMALE; FIBROBLAST GROWTH FACTOR 1; HUMANS; MITOGENS; RNA, MESSENGER; UP-REGULATION;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0032557813     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-4889(98)00033-0     Document Type: Article

References (73)

1. W. Imagawa, J. Yang, R. Gugman, S. Nandi, Control of mammary gland development, The Physiology of Reproduction, 2nd edn., Raven Press, New York, 1994, Ch. 56, pp. 1033-1063.
2. Ethier S.P., Summerfelt R.M., Cundiff K.C., Asch B.B. The influence of growth factors on the proliferative potential of normal and primary breast cancer-derived human breast epithelial cells. Breast Cancer Res. Treat. 17:1990;221-230.
3. Bates S., Valverius E., Ennis B., Bronzert D.A., Sheridan J.P., Stampfer M.R., Mendelsohn J., Lippman M.E., Dickson E.B. Expression of the transforming growth factor α/epidermal growth factor receptor pathway in normal human breast epithelial cells. Endocrinology. 126:1990;596-607.
4. Imagawa I., Cunha G.R., Young P., Nandi S. Keratinocyte growth factor and acidic fibroblast growth factor are mitogens for primary cultures of mammary epithelium. Biochem. Biophys. Res. Commun. 204:1994;1165-1169.
5. Takahashi K., Suzuki K., Kawahara S., Ono T. Growth stimulation of human breast epithelial cells by basic fibroblast growth factor in serum-free medium. Int. J. Cancer. 43:1989;870-874.
6. Braumrucker C., Stemberger B. Insulin and insulin-like growth factor I stimulate DNA synthesis in bovine mammary tissue in vitro. J. Animal Sci. 67:1989;3503-3514.
7. Zajchowski D., Band V., Pauzie N., Tager A., Stampfer M., Sager R. Expression of growth factors and oncogens in normal and tumor-derived human mammary epithelial cells. Cancer Res. 48:1988;7041-7047.
8. Yee D., Paik S., Lebovic G., Marcus R.R., Favoni R.E., Cullen K.J., Lippman M.E., Rosen N. Analysis of insulin-like growth factor-I gene expression in malignancy: evidence for a paracrine role in human breast. Mol. Endocrinol. 3:1989;509-517.
9. Forsyth I.A. Growth factors in mammary gland development. J. Reprod. Fertil. 85:1989;759-770.
10. S.L. Flamm, A. Wellstein, R. Lupu, F. Kern, M.E. Lippman, E.P. Gelmann, Expression of fibroblast growth factor peptides in normal and malignant human mammary epithelial cells, Proc. Am. Soc. Clin. Oncol. 30 (1989) 71 (Abstr. 278).
11. Gomm J.J., Smith J., Ryall G.K., Baillie R., Turnbull L., Coombes R.C. Localisation of basic fibroblast growth factor and transforming growth factor β1 in the human mammary gland. Cancer Res. 51:1991;4685-4692.
12. Bano M., Salomon D.S., Kidwell W.R. Purification of mammary-derived growth factor from human milk and human mammary tumors. J. Biol. Chem. 260:1985;5745-5752.
13. Valverius E., Walker-Jones D., Bates S., Stampfer M.R., Clark R., McCornick F., Dickson R.B., Lippman M.E. Production of and responsiveness of TGF-β in normal and oncogene-transformed human mammary epithelial cells. Cancer Res. 49:1989;6269-6274.
14. Ervin P.R.J., Kaminski M.S., Cody R.L., Wicha M.S. Production of mammastatin, a tissue-specific growth inhibitor, by normal human mammary cells. Science. 244:1989;1585-1587.
15. Böhmer F.D., Kraft R., Otto A., Wernstedt C., Hellman U., Kurtz A., Muller T., Rodhi K., Etzold G., Lehmann W. Identification of a polypeptide growth inhibitor from bovine mammary gland. J. Biol. Chem. 62:1987;15137-15431.
16. Edery M., McGrath M., Larson L., Nandi S. Correlation between in vitro growth and regulation of oestrogen and progesterone receptors in rat mammary epithelial cells. Endocrinology. 115:1984;1691-1697.
17. Gabelman B.M., Emerman J.T. Effects of oestrogen, epidermal growth factor, and transforming growth factor-α on the growth of human breast epithelial cells in primary culture. Exp. Cell Res. 201:1992;113-118.
18. B.K. Vonderhaar, Hormone and growth factors in mammary gland development, in: C.M Veneziale (Ed.), Control of Cell Growth and Proliferation. Van Nostrand-Reinhold, Princeton, NJ, 1984, pp. 11-33.
19. W.R. Kidwell, Growth factor production by mammary tumor cells, in: D. Medina, W.R. Kidwell, G. Heppner, E. Anderson (Eds.), Cellular and Molecular Biology of Mammary Cancer, Plenum, New York, 1987, pp. 239-252.
20. Monaham S., Salomon D.S., Kidwell W.R. Substratum modulation of epidermal growth factor expression by normal mammary cells. J. Dairy Sci. 71:1988;1507-1514.
21. Dickson R.B., Huff K.K., Spencer E.M., Lippman M.E. Induction of epidermal growth factor-related peptides by 17β-estradiol in MCF-7 human breast cancer cells. Endocrinology. 118:1986;138-142.
22. Bates S., Davidson N.E., Valverius E.M., Freter C.E., Dickson R.B., Tam J.P., Kudlow J.E., Lippman M.E., Salomon D.S. Expression of transforming growth factor α and its messenger ribonucleic acid in human breast cancer: its regulation by oestrogen and its possible significance. Mol. Endocrinol. 2:1988;543-555.
23. Osborne C.K., Coronado E.B., Kitten L.J., Arteaga C.I., Fuqua S., Ramasharma K., Marshall M., Li C.H. Insulin-like growth factor-II (IGF-II): a potential autocrine/paracrine growth factor for human breast cancer acting via the IGF-I receptor. Mol. Endocrinol. 3:1989;1701-1709.
24. Knabbe C.K., Lippman M.E., Wakefield L.M., Flanders K.C., Kasid A., Derynck R., Dickson R.B. Evidence that transforming growth factor-beta is a hormonally regulated negative growth factor in human breast cancer cells. Cell. 48:1987;417-428.
25. Arrick B.A., Korc M., Derynck R. Differential regulation of expression of three transforming growth factor β species in human breast cancer cell lines by estradiol. Cancer Res. 50:1990;299-303.
26. Peyrat J.P., Hondermarck H., Louchez M.M., Boilly B. Demonstration of basic fibroblast growth factor high and low affinity binding sites in human breast cancer cell lines. Cancer Comm. 3:1991;323-329.
27. Adnane J., Gaudray P., Donne C.A., Crumbley G., Jaye M., Schlessinger J., Jeanteur P., Birnbaum D., Theillet C. BEK and FLC, two receptors to members of the FGF family, are amplified in subsets of human breast cancer. Oncogene. 6:1991;659-663.
28. Theillet C., Adelaide J., Louason G., Bonnet-Dorion F., Jacquemier J., Adnane J., Longy M., Katsaros D., Sismondi P., Gaudray P., Birnbaum D. FGFR1 and PLAT genes and DNA amplification at 8p12 in breast and ovarian cancers. Genes Chrom. Cancer. 7:1993;291-326.
29. Jacquemier J., Adelaide J., Parc P., Penault-Llorca F., Planche J., De Lapeyriere O., Birnbaum D. Expression of the FGFR1 gene in human breast-carcinoma cells. Int. J. Cancer. 59:1994;373-378.
30. Johnston C.L., Cox H.C., Gomm J.J., Coombes R.C. bFGF and aFGF induce membrane ruffling in breast cancer cells but not in normal breast epithelial cells: FGFR-4 involvement. Biochem. J. 306:1995;609-616.
31. Penault-Llorca F., Bertucci F., Adelaide J., Parc P., Coulier F., Jacquemier J., Birnbaum D., De Lapeyriere O. Expression of FGF and FGF receptor genes in human breast cancer. Int. J. Cancer. 61:1995;170-176.
32. Delehedde M., Deudon E., Boilly B., Hondermarck H. Heparan sulfate proteoglycans play a dual role in regulating fibroblast growth factor-2 mitogenic activity in human breast cancer cells. Exp. Cell Res. 229:1996;398-406.
33. Karey K.P., Sirbasku D.A. Differential responsiveness of human breast cancer cell lines MCF-7 and T47-D to growth factors and 17β-estradiol. Cancer Res. 48:1988;4083-4092.
34. Briozzo P., Badet J., Capony F., Pieri I., Montcourrier P., Barritault D., Rochefort H. MCF-7 mammary cancer cells respond to bFGF and internalize it following its release from extracellular matrix: a permissive role of cathepsin D. Exp. Cell Res. 194:1991;252-259.
35. Delehedde M., Boilly B., Hondermarck H. Differential responsiveness of human breast cancer cells to basic fibroblast growth factor. A cell kinetics study. Oncol. Res. 7:1995;399-405.
36. McLeskey S.W., Ding I.Y., Lippman M.E., Kern F.G. MDA-MB-134 breast carcinoma cells overexpress fibroblast growth factor (FGF) receptors and are growth-inhibited by FGF ligands. Cancer Res. 54:1994;523-530.
37. Renaud F., El Yazidi I., Boilly-Marer Y., Courtois Y., Laurent M. Expression and regulation by serum of multiple FGF1 mRNA in normal, transformed, and malignant human mammary epithelial cells. Biochem. Biophys. Res. Commun. 219:1996;679-685.
38. Luqmani Y.A., Graham M., Coombes R.C. Expression of basic fibroblast growth factor, FGFR1 and FGFR2 in normal and malignant human breast and comparison with other normal tissues. Br. J. Cancer. 66:1992;273-280.
39. Anandappa S.Y., Winstanley J.H.R., Leinster S., Green B., Rudland P.S., Barraclough R. Comparative expression of fibroblast growth factor mRNAs in benign and malignant breast disease. Br. J. Cancer. 69:1994;772-776.
40. Souttou B., Hamelin R., Crepin M. FGF2 as an autocrine growth factor for immortal human breast epithelial cells. Cell Growth Diff. 5:1994;615-623.
41. El Yazidi I., Boilly-Marer Y. Production of acidic and basic fibroblast growth factor by the hormone-independent breast cancer cell line MDA-MB-231. Anticancer Res. 15:1995;783-790.
42. Chiu I.M., Wang W.P., Lehtoma K. Alternative splicing generates two forms of mRNA coding for human heparin-binding growth factor 1. Oncogene. 5:1990;755-762.
43. Wang W.P., Myers R.L., Chiu I.M. Single primer mediated polymerase chain reaction: application in cloning of two different 5′ untranslated sequences of acidic fibroblast growth factor mRNA. DNA Cell Biol. 10:1991;771-777.
44. Voulgaropoulou F., Myers R.L., Chiu I.M. Alternative splicing of fibroblast growth factor 1 (FGF1) transcripts: a cellular dilemma in determining exon selection and exclusion. DNA Cell Biol. 13:1994;1001-1009.
45. Meyers R.L., Payson R.A., Chotani M.A., Deaven L.L., Chiu I.M. Gene structure and differential expression of acidic fibroblast growth factor mRNA: identification and distribution of four different transcripts. Oncogene. 8:1993;341-349.
46. Philippe J.M., Renaud F., Desset S., Laurent M., Mallet J., Courtois Y., Edward J.B. Cloning of two different 5′ untranslated exons of bovine acidic fibroblast growth factor by the single strand ligation to single-stranded cDNA methodology. Biochem. Biophys. Res. Commun. 188:1992;843-850.
47. Oliver L., Raulais D., Vigny M. Acidic fibroblast growth factor (aFGF) in developing normal and dystrophic (mdx) mouse muscles. Distribution in degenerating and regenerating mdx myofibers. Growth Factors. 7:1992;97-106.
48. Myoken Y., Kan M., Chen J., McKeehan W.L., Sato G.H., Sato J.D. Monoclonal antibodies against heparin-binding growth factor-1: neutralizing of biological activity and recognition of specific amino-acid sequence. Biochem. Biophys. Res. Commun. 197:1993;1450-1457.
49. Soule H.D., Vasquez J., Long A., Albert S., Brennan M.J. A human cell line from a pleural effusion derived from breast carcinoma. J. Natl. Cancer Inst. 51:1973;1409-1416.
50. Cailleau R., Young R., Olive M., Reves W.J. Breast tumor cell lines from pleural effusions. J. Natl. Cancer Inst. 53:1974;661-674.
51. Caron de Fromentel C., Nardeux P.C., Soussi T., Laviale C., Estrade S., Carloni G., Chandrasekaran K., Cassingena R. Epithelial HBL-100 cell line derived from milk of an apparently healthy woman harbours SV40 genetic information. Exp. Cell Res. 160:1985;83-94.
52. Soule H.D., McGrath C.M. A simplified method for passage and long-term growth of human mammary epithelial cells. In Vitro Cell Dev. Biol. 22:1986;6-12.
53. Engel L.W., Young N.A. Human breast carcinoma cells in continuous culture. Cancer Res. 38:1978;4327-4339.
54. Chirgwin J.M., Przybyla A.E., McDonald R.J., Rutter W.J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 18:1979;5294-5299.
55. Feinberg A.P., Vogelstein B. A technique for radio-labelling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem. 137:1984;266-267.
56. Jaye M., Howk R., Burgess W., Ricca G.A., Chiu I.M., Ravera M.W., O'Brien S.J., Modi W.S., Maciag T., Drohan W.N. Human endothelial cell growth factor: cloning, nucleotide sequence and chromosomal localisation. Science. 233:1986;541-545.
57. Abraham J.A., Whang T.L., Tumolo A., Mergia A., Friedman J., Gospodarowicz D., Fidde J.S. Human basic fibroblast growth factor: nucleotide sequence and genomic organisation. EMBO J. 5:1986;2523-2528.
58. Baird A., Ling N. Fibroblast growth factors are present in the extracellular matrix produced by endothelial cells in vitro: implication for a role of heparinase-like enzymes in the neovascular response. Biochem. Biophys. Res. Commun. 142:1987;428-435.
59. Vlodavsky I., Folkman J., Sullivan R., Friedman R., Ishai-Michaeli R., Sasse J., Klagsbrun M. Endothelial cell-derived basic fibroblast growth factor. Synthesis and deposition into subendothelial extracellular matrix. Proc. Natl. Acad. Sci. USA. 84:1987;2292-2296.
60. Delehedde M., Deudon E., Boilly B., Hondermarck H. Production of sulfated proteoglycans by human breast cancer lines: binding to fibroblast growth factor-2. J. Cell. Biochem. 64:1997;605-617.
61. Loose-Mitchell D.S., Chiappetta C., Stancel G.M. Oestrogen regulation of c-fos messenger ribonucleic acid. Mol. Endocrinol. 2:1988;946-951.
62. Weisz A., Bresciani F. Oestrogen regulation of proto-oncogenes coding for nuclear proteins. Crit. Rev. Oncogen. 4:1993;361-388.
63. ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells. EMBO J. 15:1996;1292-1300.
64. Berthois Y., Katzenellenbogen J.A., Katzenellenbogen B.S. Phenol red in tissue culture media is a weak oestrogen: implication concerning the study of oestrogen-responsive cells in culture. Proc. Natl. Acad. Sci. USA. 83:1986;2496-2500.
65. Shaw G., Kamen R.A. Conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell. 46:1986;659-667.
66. Rao C.D., Pech M., Robbins K.C., Aaronson S.A. The 5′ untranslated sequence of the c-sis/platelet-derived growth factor 2 transcript is a potent translational inhibitor. Mol. Cell. Biol. 8:1988;284-292.
67. Nielsen F.C., Ostergaard L., Nielsen J., Christiansen J. Growth-dependent translation of IGF-II mRNA by a rapamycin-sensitive pathway. Nature. 377:1995;358-362.
68. Gottlieb E. The 3′ untranslated region of localized maternal messages contains a conserved motif involved in mRNA localization. Proc. Natl. Acad. Sci. USA. 89:1992;7164-7168.
69. Rastinejad F., Comboy M.J., Rando T.A., Blau H.M. Tumor suppression by RNA from the 3′ untranslated region of α-tropomyosine. Cell. 75:1993;1107-1117.
70. Hall J.A., Harris M.A., Malark M., Manson P.E., Zhou H., Harris S.E. Characterization of the hamster DDT-1 cell aFGF/HBGF-I gene and cDNA and its modulation by steroids. J. Cell Biochem. 43:1990;17-26.
71. Geller J., Sionit L.R., Baird A., Kohls M., Hoffman R., Connors K. In vivo and in vitro effects of androgen on FGF2 concentrations in the human prostate. Prostate. 25:1994;206-209.
72. Fujimoto J., Hori M., Ichigo S., Hirose R., Sakaguchi H., Tamaya T. Plausible novel therapeutic strategy of uterine endometrial cancer with reduction of basic fibroblast growth factor secretion by progestin and O-(chloroacetyl-carbamoyl) fumagillol (TNP-470; AGM-1470). Cancer Lett. 113:1997;187-194.
73. Mullaney B.P., Skinner M.K. Basic fibroblast growth factor (bFGF) gene expression and protein production during pubertal development of the seminiferous tubule: follicle-stimulating hormone-induced Sertoli cell bFGF expression. Endocrinology. 131:1992;2928-2934.